Abbott Laboratories
NYSE:ABT

Watchlist Manager

Abbott Laboratories

NYSE:ABT

Watchlist

Dividends

Price: 117.65 USD -0.8%

Market Cap: 204.7B USD

Have any thoughts about
Abbott Laboratories?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 117.65 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ABT Alert

Abbott Laboratories

117.65

-0.95 (-0.8%)

52 Week Range	93.55 120.96
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Abbott Laboratories

What unique competitive advantages
does Abbott Laboratories hold over its rivals?

What risks and challenges
does Abbott Laboratories face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Abbott Laboratories.

What unique competitive advantages
does Abbott Laboratories hold over its rivals?

What risks and challenges
does Abbott Laboratories face in the near future?

Has there been any significant insider trading activity
in Abbott Laboratories recently?

Summarize the latest earnings call
of Abbott Laboratories.

What significant events have occurred
in Abbott Laboratories over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abbott Laboratories.

Provide P/S
for Abbott Laboratories.

Provide P/E
for Abbott Laboratories.

Provide P/OCF
for Abbott Laboratories.

Provide P/FCFE
for Abbott Laboratories.

Provide P/B
for Abbott Laboratories.

Provide EV/S
for Abbott Laboratories.

Provide EV/GP
for Abbott Laboratories.

Provide EV/EBITDA
for Abbott Laboratories.

Provide EV/EBIT
for Abbott Laboratories.

Provide EV/OCF
for Abbott Laboratories.

Provide EV/FCFF
for Abbott Laboratories.

Provide EV/IC
for Abbott Laboratories.

Show me price targets
for Abbott Laboratories made by professional analysts.

What are the Revenue projections
for Abbott Laboratories?

How accurate were the past Revenue estimates
for Abbott Laboratories?

What are the Net Income projections
for Abbott Laboratories?

How accurate were the past Net Income estimates
for Abbott Laboratories?

What are the EPS projections
for Abbott Laboratories?

How accurate were the past EPS estimates
for Abbott Laboratories?

What are the EBIT projections
for Abbott Laboratories?

How accurate were the past EBIT estimates
for Abbott Laboratories?

Compare the revenue forecasts
for Abbott Laboratories with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abbott Laboratories and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abbott Laboratories against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abbott Laboratories compared to its peers.

Compare the P/E ratios
of Abbott Laboratories against its peers.

Discuss the investment returns and shareholder value creation
comparing Abbott Laboratories with its peers.

Analyze the financial leverage
of Abbott Laboratories compared to its main competitors.

Show all profitability ratios
for Abbott Laboratories.

Provide ROE
for Abbott Laboratories.

Provide ROA
for Abbott Laboratories.

Provide ROIC
for Abbott Laboratories.

Provide ROCE
for Abbott Laboratories.

Provide Gross Margin
for Abbott Laboratories.

Provide Operating Margin
for Abbott Laboratories.

Provide Net Margin
for Abbott Laboratories.

Provide FCF Margin
for Abbott Laboratories.

Show all solvency ratios
for Abbott Laboratories.

Provide D/E Ratio
for Abbott Laboratories.

Provide D/A Ratio
for Abbott Laboratories.

Provide Interest Coverage Ratio
for Abbott Laboratories.

Provide Altman Z-Score Ratio
for Abbott Laboratories.

Provide Quick Ratio
for Abbott Laboratories.

Provide Current Ratio
for Abbott Laboratories.

Provide Cash Ratio
for Abbott Laboratories.

What is the historical Revenue growth
over the last 5 years for Abbott Laboratories?

What is the historical Net Income growth
over the last 5 years for Abbott Laboratories?

What is the current Free Cash Flow
of Abbott Laboratories?

Discuss the annual earnings per share (EPS)
trend over the past five years for Abbott Laboratories.

ABT

Income Statement

Income from Continuing Operations

Abbott Laboratories
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Abbott Laboratories
Income from Continuing Operations Peer Comparison

Comparables:

BDX

BSX

SYK

ISRG

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

	Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
Abbott Laboratories NYSE:ABT	Income from Continuing Operations $5.8B	CAGR 3-Years -7%	CAGR 5-Years 12%	CAGR 10-Years 14%
Becton Dickinson and Co NYSE:BDX	Income from Continuing Operations $1.5B	CAGR 3-Years 11%	CAGR 5-Years 3%	CAGR 10-Years 4%
Boston Scientific Corp NYSE:BSX	Income from Continuing Operations $1.8B	CAGR 3-Years 16%	CAGR 5-Years 12%	CAGR 10-Years 20%
Edwards Lifesciences Corp NYSE:EW	Income from Continuing Operations $1.4B	CAGR 3-Years -1%	CAGR 5-Years 12%	CAGR 10-Years 6%
Stryker Corp NYSE:SYK	Income from Continuing Operations $3.6B	CAGR 3-Years 24%	CAGR 5-Years 14%	CAGR 10-Years 19%
Intuitive Surgical Inc NASDAQ:ISRG	Income from Continuing Operations $2.3B	CAGR 3-Years 10%	CAGR 5-Years 12%	CAGR 10-Years 18%

What is Abbott Laboratories's Income from Continuing Operations?

Income from Continuing Operations
5.8B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Income from Continuing Operations amounts to 5.8B USD.

What is Abbott Laboratories's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
14%

Over the last year, the Income from Continuing Operations growth was 12%. The average annual Income from Continuing Operations growth rates for Abbott Laboratories have been -7% over the past three years , 12% over the past five years , and 14% over the past ten years .

Abbott Laboratories
NYSE:ABT

Abbott Laboratories
Income from Continuing Operations

Abbott Laboratories
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Abbott Laboratories's Income from Continuing Operations?

Income from Continuing Operations
5.8B USD

What is Abbott Laboratories's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
14%

Company

Help

Tools

Stocks

Abbott Laboratories NYSE:ABT

Abbott Laboratories Income from Continuing Operations

Abbott Laboratories Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Abbott Laboratories's Income from Continuing Operations? Income from Continuing Operations 5.8B USD

What is Abbott Laboratories's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 10Y 14%

Company

Help

Tools

Stocks

Abbott Laboratories
NYSE:ABT

Abbott Laboratories
Income from Continuing Operations

Abbott Laboratories
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Abbott Laboratories's Income from Continuing Operations?

Income from Continuing Operations
5.8B USD

What is Abbott Laboratories's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
14%